Kimberly-Clark agrees to buy Tylenol owner Kenvue in $48.7 billion deal, creating consumer staples giant
From the Left
AllSides Media Bias Rating: Lean Left
Kimberly-Clark announced Monday it’s struck an agreement to buy Kenvue in a deal valued at $48.7 billion that would create a consumer staples giant.
Check for Bias
The AI-powered AllSides Bias Checker instantly reveals the bias of a news article. Tap the button to use.
Related Coverage
AllSides Picks
More News about Healthcare
News from the Left
News from the Center
News from the Right
These five states are putting transgender sports, gender-medicine questions before voters next month
Just The News